218 related articles for article (PubMed ID: 11018787)
1. Effect of amphetamine on extrastriatal D2 dopamine receptor binding in the primate brain: a PET study.
Chou YH; Halldin C; Farde L
Synapse; 2000 Nov; 38(2):138-43. PubMed ID: 11018787
[TBL] [Abstract][Full Text] [Related]
2. Effect of endogenous dopamine on extrastriatal [¹¹C]FLB 457 binding measured by PET.
Okauchi T; Suhara T; Maeda J; Kawabe K; Obayashi S; Suzuki K
Synapse; 2001 Aug; 41(2):87-95. PubMed ID: 11400175
[TBL] [Abstract][Full Text] [Related]
3. Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain.
Olsson H; Halldin C; Swahn CG; Farde L
J Cereb Blood Flow Metab; 1999 Oct; 19(10):1164-73. PubMed ID: 10532641
[TBL] [Abstract][Full Text] [Related]
4. Carbon-11-FLB 457: a radioligand for extrastriatal D2 dopamine receptors.
Halldin C; Farde L; Högberg T; Mohell N; Hall H; Suhara T; Karlsson P; Nakashima Y; Swahn CG
J Nucl Med; 1995 Jul; 36(7):1275-81. PubMed ID: 7790956
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of extrastriatal D2 receptors using a very high-affinity ligand (FLB 457) and the multi-injection approach.
Delforge J; Bottlaender M; Loc'h C; Guenther I; Fuseau C; Bendriem B; Syrota A; Mazière B
J Cereb Blood Flow Metab; 1999 May; 19(5):533-46. PubMed ID: 10326721
[TBL] [Abstract][Full Text] [Related]
6. Reference region modeling approaches for amphetamine challenge studies with [11C]FLB 457 and PET.
Sandiego CM; Gallezot JD; Lim K; Ropchan J; Lin SF; Gao H; Morris ED; Cosgrove KP
J Cereb Blood Flow Metab; 2015 Mar; 35(4):623-9. PubMed ID: 25564239
[TBL] [Abstract][Full Text] [Related]
7. Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine.
Janowsky A; Neve KA; Kinzie JM; Taylor B; de Paulis T; Belknap JK
J Pharmacol Exp Ther; 1992 Jun; 261(3):1282-90. PubMed ID: 1534844
[TBL] [Abstract][Full Text] [Related]
8. Amphetamine pretreatment induces a change in both D2-Receptor density and apparent affinity: a [11C]raclopride positron emission tomography study in cats.
Ginovart N; Wilson AA; Houle S; Kapur S
Biol Psychiatry; 2004 Jun; 55(12):1188-94. PubMed ID: 15184038
[TBL] [Abstract][Full Text] [Related]
9. Striatal and extrastriatal dopamine D2 receptor occupancy by a novel antipsychotic, blonanserin: a PET study with [11C]raclopride and [11C]FLB 457 in schizophrenia.
Tateno A; Arakawa R; Okumura M; Fukuta H; Honjo K; Ishihara K; Nakamura H; Kumita S; Okubo Y
J Clin Psychopharmacol; 2013 Apr; 33(2):162-9. PubMed ID: 23422369
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride.
Narendran R; Frankle WG; Mason NS; Rabiner EA; Gunn RN; Searle GE; Vora S; Litschge M; Kendro S; Cooper TB; Mathis CA; Laruelle M
Synapse; 2009 Jun; 63(6):447-61. PubMed ID: 19217025
[TBL] [Abstract][Full Text] [Related]
11. Absolute quantification by positron emission tomography of the endogenous ligand.
Delforge J; Bottlaender M; Pappata S; Loc'h C; Syrota A
J Cereb Blood Flow Metab; 2001 May; 21(5):613-30. PubMed ID: 11333372
[TBL] [Abstract][Full Text] [Related]
12. Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels.
Dewey SL; Smith GS; Logan J; Brodie JD; Fowler JS; Wolf AP
Synapse; 1993 Apr; 13(4):350-6. PubMed ID: 8480281
[TBL] [Abstract][Full Text] [Related]
13. In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.
Narendran R; Hwang DR; Slifstein M; Talbot PS; Erritzoe D; Huang Y; Cooper TB; Martinez D; Kegeles LS; Abi-Dargham A; Laruelle M
Synapse; 2004 Jun; 52(3):188-208. PubMed ID: 15065219
[TBL] [Abstract][Full Text] [Related]
14. Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy--a simulation study based on experimental data.
Olsson H; Farde L
Neuroimage; 2001 Oct; 14(4):936-45. PubMed ID: 11554812
[TBL] [Abstract][Full Text] [Related]
15. In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]-(+)-PHNO in rats using an intracerebral beta-sensitive system.
Galineau L; Wilson AA; Garcia A; Houle S; Kapur S; Ginovart N
Synapse; 2006 Aug; 60(2):172-83. PubMed ID: 16715499
[TBL] [Abstract][Full Text] [Related]
16. Kinetic modeling of [11C]raclopride: combined PET-microdialysis studies.
Endres CJ; Kolachana BS; Saunders RC; Su T; Weinberger D; Breier A; Eckelman WC; Carson RE
J Cereb Blood Flow Metab; 1997 Sep; 17(9):932-42. PubMed ID: 9307606
[TBL] [Abstract][Full Text] [Related]
17. Changes in striatal D2-receptor density following chronic treatment with amphetamine as assessed with PET in nonhuman primates.
Ginovart N; Farde L; Halldin C; Swahn CG
Synapse; 1999 Feb; 31(2):154-62. PubMed ID: 10024013
[TBL] [Abstract][Full Text] [Related]
18. Alfentanil increases cortical dopamine D2/D3 receptor binding in healthy subjects.
Hagelberg N; Aalto S; Kajander J; Oikonen V; Hinkka S; Någren K; Hietala J; Scheinin H
Pain; 2004 May; 109(1-2):86-93. PubMed ID: 15082129
[TBL] [Abstract][Full Text] [Related]
19. Low convergent validity of [
Freiburghaus T; Svensson JE; Matheson GJ; Plavén-Sigray P; Lundberg J; Farde L; Cervenka S
Neuroimage; 2021 Feb; 226():117523. PubMed ID: 33144221
[TBL] [Abstract][Full Text] [Related]
20. PET studies of D2-receptor binding in striatal and extrastriatal brain regions: Biochemical support in vivo for separate dopaminergic systems in humans.
Cervenka S; Varrone A; Fransén E; Halldin C; Farde L
Synapse; 2010 Jun; 64(6):478-85. PubMed ID: 20175222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
